DK161152C - Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat - Google Patents
Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparatInfo
- Publication number
- DK161152C DK161152C DK098884A DK98884A DK161152C DK 161152 C DK161152 C DK 161152C DK 098884 A DK098884 A DK 098884A DK 98884 A DK98884 A DK 98884A DK 161152 C DK161152 C DK 161152C
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptide
- preparation
- dna
- vector
- growth factor
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title 4
- 108090000765 processed proteins & peptides Proteins 0.000 title 3
- 102000004196 processed proteins & peptides Human genes 0.000 title 3
- 108020004414 DNA Proteins 0.000 title 1
- 101001111439 Homo sapiens Beta-nerve growth factor Proteins 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 title 1
- 239000013604 expression vector Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
- 102000015336 Nerve Growth Factor Human genes 0.000 abstract 1
- 108010025020 Nerve Growth Factor Proteins 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 229940053128 nerve growth factor Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47196283A | 1983-03-03 | 1983-03-03 | |
| US47196283 | 1983-03-03 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK98884D0 DK98884D0 (da) | 1984-02-24 |
| DK98884A DK98884A (da) | 1984-10-04 |
| DK161152B DK161152B (da) | 1991-06-03 |
| DK161152C true DK161152C (da) | 1991-11-11 |
Family
ID=23873671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK098884A DK161152C (da) | 1983-03-03 | 1984-02-24 | Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0121338B2 (fr) |
| JP (4) | JPS6084299A (fr) |
| KR (1) | KR840008026A (fr) |
| AT (1) | ATE45382T1 (fr) |
| AU (1) | AU574350B2 (fr) |
| CA (1) | CA1220736A (fr) |
| DE (1) | DE3479321D1 (fr) |
| DK (1) | DK161152C (fr) |
| ES (1) | ES8600783A1 (fr) |
| IE (1) | IE57013B1 (fr) |
| NZ (1) | NZ207337A (fr) |
| ZA (1) | ZA841597B (fr) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987001728A1 (fr) * | 1985-09-12 | 1987-03-26 | Biotechnology Research Partners, Ltd. | Facteurs de croissance de fibroblaste recombinant |
| JPH01102096A (ja) * | 1987-10-15 | 1989-04-19 | Sanwa Kagaku Kenkyusho Co Ltd | モチリン様活性を有するポリペプチド、その発現用微生物及び該ポリペプチドの製法 |
| JPH01211490A (ja) * | 1988-02-19 | 1989-08-24 | Tosoh Corp | ヒト神経成長因子遺伝子セグメント |
| IT1219874B (it) * | 1988-03-18 | 1990-05-24 | Fidia Farmaceutici | Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche |
| US5134121A (en) * | 1988-03-28 | 1992-07-28 | Regents Of The University Of California | Nerve growth factor peptides |
| US5683894A (en) * | 1988-04-29 | 1997-11-04 | University Of California | Recombinant nerve growth factor |
| JPH0771509B2 (ja) * | 1988-07-12 | 1995-08-02 | 工業技術院長 | ヒトβ−ＮＧＦの発現法 |
| US5082774A (en) * | 1988-08-30 | 1992-01-21 | The General Hospital Corporation | Recombinant human nerve growth factor |
| US5272063A (en) * | 1988-11-22 | 1993-12-21 | Syntex (U.S.A.) Inc. | Process of making human nerve growth factor |
| US6709837B1 (en) | 1989-03-10 | 2004-03-23 | Takeda Chemical Industries, Inc. | Polypeptide and production thereof |
| SE8901715L (sv) * | 1989-05-12 | 1990-11-13 | Lope Medicine Ab | En plasmid dna-konstruktion innehaallande dna-sekvenser |
| IT1232157B (it) * | 1989-07-20 | 1992-01-25 | Fidia Farmaceutici | Purificazione del fattore di crescita nervoso tramite cromatografia a scambio di subunita' |
| DE69017793T2 (de) * | 1989-08-21 | 1995-08-24 | Takeda Chemical Industries Ltd | Produktion von menschlichen Nervenwachstumsfaktoren. |
| US5656435A (en) * | 1989-08-28 | 1997-08-12 | Takeda Chemical Industries, Ltd. | Antibodies to peptides having NGF-like activity, said antibodies having no substantial cross-reactivity with NGF, and use thereof |
| GR1000980B (el) * | 1989-08-30 | 1993-03-31 | Max Planck Gesellschaft | Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο. |
| US5180820A (en) * | 1989-08-30 | 1993-01-19 | Barde Yves Alain | Brain-derived neurotrophic factor |
| US6933276B1 (en) | 1989-08-30 | 2005-08-23 | Regeneron Pharmaceuticals, Inc. | Methods of treating peripheral neuropathies using neurotrophin-3 |
| IT1238348B (it) * | 1989-11-16 | 1993-07-13 | Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote. | |
| JPH03244385A (ja) * | 1990-02-21 | 1991-10-31 | Hitachi Ltd | ヒト神経成長因子の遺伝子工学的生産方法 |
| IT1239271B (it) * | 1990-02-27 | 1993-10-01 | Fidia Spa | Processo per l'espressione del fattore di crescita nervoso umano in cellule di artropoda frugiperda via infezione con baculovirus ricombinante |
| US5986070A (en) * | 1990-04-06 | 1999-11-16 | Amgen Inc. | Production of biologically active NGF proteins |
| US5606031A (en) * | 1990-04-06 | 1997-02-25 | Lile; Jack | Production and purification of biologically active recombinant neurotrophic protein in bacteria |
| US5235043A (en) * | 1990-04-06 | 1993-08-10 | Synergen, Inc. | Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins |
| PT100580A (pt) * | 1991-06-12 | 1993-09-30 | Regeneron Pharma | Producao e recuperacao de neurotrofinas recombinantes |
| US5389529A (en) * | 1991-06-12 | 1995-02-14 | Regeneron Pharmaceuticals, Inc. | Modified lamβ signal sequence and processes for producing recombinant neurotrophins |
| DE4139000A1 (de) | 1991-11-27 | 1993-06-03 | Boehringer Mannheim Gmbh | Verfahren zur gentechnologischen herstellung von biologisch aktivem ss-ngf |
| US6063757A (en) * | 1995-11-29 | 2000-05-16 | Urso; Richard G. | Wound treatment method with nerve growth factor |
| DE69738302T2 (de) * | 1996-09-11 | 2008-09-04 | Dainippon Sumitomo Pharma Co., Ltd. | Neues semaphorin-gen: semaphorin y |
| CN1268639C (zh) | 1996-11-15 | 2006-08-09 | 基因技术股份有限公司 | 神经营养蛋白的纯化 |
| CA2280211A1 (fr) * | 1997-02-06 | 1998-08-13 | Hoechst Marion Roussel, Inc. | Promoteurs de l'exon 1 et de l'exon 3 du facteur humain de croissance du tissu nerveux |
| US6197551B1 (en) * | 1998-01-27 | 2001-03-06 | Millennium Pharmaceuticals, Inc. | Spoil-1 protein and nucleic acid molecules and uses therefor |
| ITRM20050045A1 (it) * | 2005-02-02 | 2006-08-03 | Consiglio Nazionale Ricerche | Proteina isolata da eisenia foetida simile all'ngf umano e usi relativi. |
| US7300691B2 (en) | 2005-09-27 | 2007-11-27 | Milliken & Company | Moldable construction incorporating non-olefin bonding interface |
| US7378359B2 (en) | 2005-09-27 | 2008-05-27 | Eleazer Howell B | Moldable fibrous construction incorporating non-woven layers |
| US7294384B2 (en) | 2005-09-27 | 2007-11-13 | Milliken & Company | Moldable construction incorporating bonding interface |
| US20080124513A1 (en) | 2006-09-11 | 2008-05-29 | Eleazer Howell B | Moldable fabric with unidirectional tape yarns |
| JP6767688B2 (ja) | 2015-05-20 | 2020-10-14 | パナソニックＩｐマネジメント株式会社 | 室内空調システム |
| IT202000005542A1 (it) | 2020-03-16 | 2021-09-16 | Themis S R L | Metodo cosmetico per il trattamento della pelle e per la ricrescita dei capelli |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4185095A (en) † | 1977-11-23 | 1980-01-22 | The Massachusetts General Hospital | Nerve growth factor |
| ZA811368B (en) † | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
-
1984
- 1984-02-24 DK DK098884A patent/DK161152C/da not_active IP Right Cessation
- 1984-03-01 NZ NZ207337A patent/NZ207337A/en unknown
- 1984-03-01 IE IE493/84A patent/IE57013B1/en not_active IP Right Cessation
- 1984-03-01 ES ES530202A patent/ES8600783A1/es not_active Expired
- 1984-03-02 DE DE8484301377T patent/DE3479321D1/de not_active Expired
- 1984-03-02 ZA ZA841597A patent/ZA841597B/xx unknown
- 1984-03-02 KR KR1019840001051A patent/KR840008026A/ko not_active Application Discontinuation
- 1984-03-02 AT AT84301377T patent/ATE45382T1/de not_active IP Right Cessation
- 1984-03-02 CA CA000448766A patent/CA1220736A/fr not_active Expired
- 1984-03-02 JP JP59041205A patent/JPS6084299A/ja active Granted
- 1984-03-02 AU AU25252/84A patent/AU574350B2/en not_active Expired
- 1984-03-02 EP EP84301377A patent/EP0121338B2/fr not_active Expired - Lifetime
-
1992
- 1992-07-13 JP JP4185044A patent/JP2740417B2/ja not_active Expired - Lifetime
- 1992-12-25 JP JP4346109A patent/JPH067169A/ja active Pending
- 1992-12-25 JP JP4346116A patent/JP2898494B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0121338A1 (fr) | 1984-10-10 |
| NZ207337A (en) | 1987-11-27 |
| DE3479321D1 (en) | 1989-09-14 |
| KR840008026A (ko) | 1984-12-12 |
| IE840493L (en) | 1984-09-03 |
| AU2525284A (en) | 1984-09-06 |
| AU574350B2 (en) | 1988-07-07 |
| JPH0690764A (ja) | 1994-04-05 |
| JPH05310792A (ja) | 1993-11-22 |
| JPH0536031B2 (fr) | 1993-05-28 |
| DK98884D0 (da) | 1984-02-24 |
| CA1220736A (fr) | 1987-04-21 |
| EP0121338B1 (fr) | 1989-08-09 |
| ATE45382T1 (de) | 1989-08-15 |
| DK161152B (da) | 1991-06-03 |
| JPH067169A (ja) | 1994-01-18 |
| IE57013B1 (en) | 1992-03-11 |
| ES530202A0 (es) | 1985-11-01 |
| JP2898494B2 (ja) | 1999-06-02 |
| ES8600783A1 (es) | 1985-11-01 |
| JPS6084299A (ja) | 1985-05-13 |
| JP2740417B2 (ja) | 1998-04-15 |
| EP0121338B2 (fr) | 1999-10-27 |
| DK98884A (da) | 1984-10-04 |
| ZA841597B (en) | 1984-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK161152C (da) | Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat | |
| DK460882A (da) | Dna-sekvens, der koder for humant immun-interferon, replicerbareudtrykkelsesmedier herfor, mikroorganisme- eller cellekulturer transformeret med saadanne og fremgangsmaade til fremstilling af et polypeptid, der omfatter aminosyresekvensen af humant immun-interferon | |
| DK144695A (da) | Ekspressionsvektor eller et par af ekspressionsvektorer omfattende heterolog DNA, som koder for alfa- og beta-underenhederne af humant FSH, eukatyotisk celle transficeret med vektoren eller parret af vektorer, fremgangsmåde til fremstilling af biologisk aktivt heterodimert humant FSH og fremgangsmåde til fremstilling af et farmaceutisk præparat indeholdende rekombinant humant FSH | |
| ES549539A0 (es) | Un metodo para la preparacion de eritropoyetina. | |
| FI102075B1 (fi) | Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit | |
| BG49941A3 (en) | Method for preparing recombinated colonniade stimulating factor- 1 | |
| YU47735B (sh) | Postupak za sintezu biološki aktivnih polipeptida limfotoksina | |
| DK13788D0 (da) | Fremgangsmaade til fremstilling af et polypeptid | |
| DK0423302T3 (da) | Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner | |
| DK165750C (da) | Fremgangsmaade til fremstilling af humant gamma-interferonlignende polypeptid, polydeoxyribonucleotid, der koder for polypeptidet, plasmid indeholdende polydeoxyribonucleotidet samt en vaert for dette plasmid | |
| ES8605296A1 (es) | Procedimiento de producir factor viii-r humano | |
| DK171825B1 (da) | DNA, som koder for human protein S herunder et polypeptid med human protein S-aktivitet, DNA-vektorer, værtsceller herunder cellekulturer, som er transformeret med disse vektorer, fremgangsmåde til fremstilling af human protein S, humant protein S fremstillet ved fremgangsmåden samt farmaceutisk middel, der består af humant protein S |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |